IPP Bureau
Sirio Pharma and Best Formulations announce US gummy manufacturing capabilities
By IPP Bureau - October 16, 2023
The new gummy capabilities include a dedicated R&D lab, an automated production line, and bottle packaging solutions
Evonik and Shandong Vland Biotech form JV in China with focus on gut health products for animals
By IPP Bureau - October 14, 2023
Evonik China and Shandong Vland Biotech agreed to build a joint venture to expand their presence in gut health solutions products for farm animals globally
Philips Visual Patient Avatar pioneers at-a-glance patient data for faster, better decision-making in the operating room
By IPP Bureau - October 14, 2023
Animations, colors, and shapes help to improve poor situational awareness, which is responsible for 81.5% of anesthesia-related errors
Dr Reddy's Bachupally biologics facility gets USFDA Form 483 with 9 observations
By IPP Bureau - October 14, 2023
The USFDA inspectors issued the observations after a product pre-approval inspection of the biologics facility in Bachupally
Venus Remedies expands reach with the launch of Elores in Ecuador
By IPP Bureau - October 14, 2023
The launch of Elores in Ecuador is expected to open the doors for the entry of the novel antibiotic adjuvant entity in other important Latin American countries
Shilpa Medicare launches 'Oraal’ for treatment of oral mucositis
By IPP Bureau - October 13, 2023
The composition of ORAAL is protected by a granted patent in India until November 2033
Lupin gets tentative approval from USFDA for Calcium, Magnesium, Potassium, and Sodium Oxybates Oral Solution
By IPP Bureau - October 13, 2023
Lupin is exclusive first-to-file and may be eligible to receive a 180-day exclusivity period at product launch
Ichnos Sciences inks agreement with Astria Therapeutics for OX40 antagonist monoclonal antibody portfolio
By IPP Bureau - October 13, 2023
Astria will assume full cost and responsibility for the global development and commercialization of the licensed therapeutic program for all indications
IMI 5.0 campaign with special focus on improvement of Measles and Rubella vaccination coverage
By IPP Bureau - October 13, 2023
Over 34 lakh children and 6 lakh pregnant women were administered vaccine doses during the first 2 rounds of IMI 5.0 campaign across the country
GlobalData predicts product cannibalization within electrophysiology ablation space
By IPP Bureau - October 12, 2023
PFA technology is only marketed in Europe, and yet, it has been dominating the electrophysiology market by storm
Allergan’s conclave on World Sight Day spotlights eyecare's crucial role in workplace
By IPP Bureau - October 12, 2023
India confronts alarming rates of eye disorders, propelling the urgency of eyecare awareness
Mandaviya inaugurates new facilities at NIMHANS and launches new logo of Tele-MANAS
By IPP Bureau - October 11, 2023
Tele-MANAS has counseled more than 3,50,000 people till date and currently provides counseling to 2000 people through 44 Tele Manas Cells
Ayurveda benefits animal, plant and human life, says Sonowal
By IPP Bureau - October 11, 2023
Ayush Minister launched month long ayurveda celebration drive of Ministry of Ayush
Eni and Dompe farmaceutici join forces for health research
By IPP Bureau - October 11, 2023
Eni will guarantee Dompé researchers access to its laboratories, support from the company's specialized staff, and use of its HPC5 supercomputer
AstraZeneca’s Tagrisso to lead lung cancer small molecule market with over $7 billion sales by 2029, says GlobalData
By IPP Bureau - October 11, 2023
Tagrisso is projected to be a pivotal contributor to AstraZeneca’s portfolio
